Bajpai J, Kapu V, Rath S, Kumar S, et al. Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, Lancet Oncol 2024;25:246-254.
PMID: 38224701